BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,500.00
-30.00 (-0.54%)
At close: Jul 17, 2025, 3:30 PM KST
-38.13%
Market Cap27.05B
Revenuen/a
Net Incomen/a
Shares Out4.86M
EPSn/a
PE Ration/a
Forward PEn/a
Dividend400.00 (7.27%)
Ex-Dividend DateDec 27, 2024
Volume10,131
Average Volume6,715
Open5,470.00
Previous Close5,530.00
Day's Range5,470.00 - 5,730.00
52-Week Range4,965.00 - 11,580.00
Beta0.83
RSI41.54
Earnings Daten/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

News

There is no news available yet.